Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Hypertrophic cardiomyopathy (HCM) is a common inherited heart condition with varied symptoms.
• Detecting and managing arrhythmias is crucial for HCM patient care.
• Current guidelines recommend periodic ambulatory ECG monitoring for arrhythmia screening.

Purpose of the Study:

• To review evidence and knowledge gaps regarding enhanced arrhythmia monitoring in HCM.
• To evaluate the potential benefits of more frequent or prolonged ECG monitoring.
• To discuss the role of cardiac implantable electronic devices in early arrhythmia detection.

Main Methods:

• Review of current literature and clinical guidelines.
• Analysis of the implications of the 2020 American Heart Association/American College of Cardiology HCM guidelines.
• Discussion of the potential merits of advanced arrhythmia detection strategies.

Main Results:

• Updated guidelines suggest increased frequency or duration of ECG monitoring for HCM patients.
• Earlier arrhythmia detection could facilitate timely treatment.
• Cardiac implantable electronic devices offer a platform for continuous monitoring.

Conclusions:

• The effectiveness of intensified arrhythmia monitoring strategies on HCM patient outcomes requires further investigation.
• Early detection and management of arrhythmias are key to improving HCM prognosis.
• Cardiac implantable electronic devices represent a promising tool for proactive arrhythmia management in HCM.